NF Center Researchers Discover a New Target for Potential MPNST Treatment

In an effort to discover new genetic mutations in malignant peripheral nerve sheath tumors (MPNSTs), deadly sarcomas , Dr. Angela Hirbe and her colleagues at the Washington University NF Center employed a sequencing platform currently available to most cancer patients. This screening platform was designed to detect mutations in genes that can be targeted by novel drug compounds.